Verve Therapeutics
Alexandra Chadwick is a highly skilled professional in the biochemistry field, currently serving as the Director of Editing & Discovery at Verve Therapeutics since September 2018, after previously holding the position of Associate Director in Preclinical R&D. Prior to joining Verve Therapeutics, Alexandra was a Postdoctoral Research Fellow at the University of Pennsylvania from March 2016 to September 2018. Alexandra earned a Doctor of Philosophy (PhD) in Biochemistry from the Medical College of Wisconsin, completing the degree in 2016, and holds a Bachelor of Science (BS) from the University of Michigan, obtained in 2009. Alexandra's academic journey began at Ernest W. Seaholm High School, where a High School Diploma was earned in 2005.
This person is not in any teams
This person is not in any offices
Verve Therapeutics
59 followers
Verve Therapeutics is a biotechnology company focused on discovering and developing therapies that safely edit the genomes of adults to confer lifelong protection against coronary artery disease, the most common type of heart disease and the leading cause of death worldwide.